Tomorrow I am traveling to CERN, where I have been invited to give a seminar at a meeting of the LHCb experiment. My talk will discuss the issue of the energy calibration of b-quark jets, a topic to which I have devoted a good part of my research time for the last thirteen years. The talk will of course be centred on the explanation of the analysis Julien Donini and I, together with a few colleagues, performed in CDF a few years ago, the search for Z boson decays to b-quark jet pairs.

NEW YORK and BERLIN, June 15 /PRNewswire/ --

- 200 photographs by 70 renowned photographers

- Estimates from US$1,000 to US$20,000

- June 15 - 25, 2009

From June 15-25 artnet Auctions will feature Icons: 20th-21st Century Photographic Portraits, a special sale of 200 original fine art photographs of legendary figures including The Beatles, Madonna, Marilyn Monroe, President Barack Obama and Elvis Presley.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/artnet/38797/

(Photo: http://www.newscom.com/cgi-bin/prnh/20090615/NY30987 )

Screen Sirens

GREIFENSEE, Switzerland, June 15 /PRNewswire/ --

- New Enhanced Functionalities Offer Users Immediate Results, Easier Handling and More Opportunities to Speed up Their Weighing Processes

MAARSSEN, Netherlands, June 15 /PRNewswire/ --

CPhI Worldwide returns to Paris for 2010 when, with ICSE, PMEC and BioPh, the world's leading pharma services industry event will be staged at Paris-Nord Villepinte on Tuesday 5 - Thursday 7 October. This is a week earlier than the 2009 event in Madrid, but close to the dates of the last staging in Paris, in 2006.

Organisers UBM International Media expect the quartet of co-located events to rival the 25,000+ attendees expected this year in Madrid. The 2006 events in Paris hosted over 22,000 attendees.

SAN DIEGO, June 15 /PRNewswire/ --

Amira Pharmaceuticals, Inc. announced today that it will present preclinical data from its LPA1 receptor antagonist program on June 30, 2009 at the Federation of American Societies for Experimental Biology (FASEB) Summer Research Conference in Carefree, Arizona.

The LPA1 receptor is part of the Phosphatidic Acid/Lysophosphatidylcholine pathway, which among other things is associated with cell to cell communication. In recent studies, it has been shown to potentially play a role in fibrotic disease, specifically Idiopathic Pulmonary Fibrosis (IPF).

PERTHSHIRE, Scotland, June 15 /PRNewswire/ --

As global energy usage is projected in 2030 to have risen 60 percent from 1980, CEOs of global corporations are increasingly looking for solutions to reduce energy consumption and to build a financially-driven business case to do so.(1)

This global search for a financial energy efficiency imperative will be a core focus of discussion among multinational CEOs, business and political world leaders at the Forbes CEO Forum in Scotland on June 14-16. Private and public sector executives are finding that translating energy efficiency into a measurable return on investment (ROI) while ensuring environmental responsibility is essential to their financial well-being.

ST JOHN'S, Antigua, June 15 /PRNewswire/ --

- Renowned Bodog.com Domain Becomes Brand's Global Portal

Bodog Europe joins Bodog Asia and the Morris Mohawk Gaming Group in celebrating the triumphant return of http://www.bodog.com as the Bodog brand's global online portal. Bodog's US brand licensee, the Morris Mohawk Gaming Group, acquired the domain earlier this year and will be operating its site at that URL. However, the world-renowned http://www.bodog.com domain will be the global portal for all brand licensees worldwide.

INDIANAPOLIS, June 15 /PRNewswire/ --

- Goal is to foster open collaboration between Lilly and global laboratory researchers

Alzheimer's disease. Cancer. Diabetes. Osteoporosis.

These are the diseases for which Eli Lilly and Company will be engaging researchers from around the world in a new and unique drug discovery initiative.

The initiative, called the Lilly Phenotypic Drug Discovery Initiative, or PD2 (pronounced PD-squared)*, uses Lilly-developed disease-state assays and a secure web portal to evaluate the therapeutic potential of compounds synthesized in university and biotechnology laboratories. Findings from this initiative could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions.

AMSTERDAM, June 15 /PRNewswire/ -- Ticket Service Nederland, a Ticketmaster Entertainment, Inc., (NASDAQ:TKTM) operating business, Paradiso corporation and Melkweg corporation today announced a multi-year extension of their more than decade-long ticketing partnership. The agreement extends Ticketmaster's exclusive ticketing for Paradiso and Melkweg (Milkyway) for all Events taking place in these Music Venues. Both multi-purpose Venues are situated in the very centre of Amsterdam and are renowned worldwide for their ambiance supplying the ultimate live Music experience for over 1.000.000 enthusiastic visitors yearly.

WELLESLEY HILLS, Massachusetts, June 15 /PRNewswire/ --

Joseph F. Finn, Jr., C.P.A. (Finn) announced today that in vitro studies have demonstrated that GCS-100 binds to and blocks the effects of galectin-3. Galectin-3 plays an important role in tumor cell survival, new blood vessel growth, cell proliferation and tumor metastasis, which is the spread of cancer beyond its primary site. As a result, this product candidate may have multiple benefits in combating cancer cells, including:

- Induction of apoptosis

- Inhibition of angiogenesis

- Inhibition of cancer cell proliferation

- Inhibition of metastasis